InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38
United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
John P. Butler
4 Mar 2026
CEO and President
Buy
69,270
$1.25
$86.59K
Adrian Adams
20 Nov 2019
Director
Buy
50,000
$3.41
$170.50K
John P. Butler
20 Nov 2019
CEO and President
Buy
50,000
$3.44
$172.00K
Steven Keith Burke
20 Nov 2019
SVP, Chief Medical Officer
Buy
27,000
$3.58
$96.66K
Cynthia Smith
20 Nov 2019
Director
Buy
15,000
$3.52
$52.80K
Steven C Gilman
20 Nov 2019
Director
Buy
5,800
$3.43
$19.89K
Muneer A Satter
5 Jul 2017
Director
Buy indirect
1,034,482
$14.50
$15.00M
Show all 139 transactions →

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 1
Sales at will 96
Transactions with no price 0
Shares from compensation/vesting 12,885,944
Sales filed before the plan box existed 83
History held since 26 Mar 2014